Ketamine effects on bupivacaine local anaesthetic activity and pharmacokinetics of bupivacaine in mice

Life Sciences

Volumn 61, Issue 20, 1997, Pages 2027-2033

  Gantenbein, M ^b   Abat, C ^b   Attolini, L ^b   Pisano, P ^b   Emperaire, N ^b   Bruguerolle, B ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b NONE

Author keywords

Bupivacaine; Ketamine; Local anaesthetics; Mice; Pharmacodynamics; Pharmacokinetics

Indexed keywords

BUPIVACAINE; KETAMINE; LOCAL ANESTHETIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG POTENCY; DRUG POTENTIATION; LOCAL ANESTHESIA; MOUSE; NERVE BLOCK; NONHUMAN; SCIATIC NERVE;

ANESTHESIA, LOCAL; ANESTHETICS, DISSOCIATIVE; ANESTHETICS, LOCAL; ANIMALS; BUPIVACAINE; DRUG INTERACTIONS; HALF-LIFE; KETAMINE; MALE; MICE;

ANIMALIA;

EID: 0030730355     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00861-8     Document Type: Article

References (19)

1. E.G. DOWDY, K. KAYA and Y. GOCHO, Anesth. Analg. 52 839-842 (1973)
2. Z. DURRANI, A.P. WINNIE , E.K. ZSIGMOND and M.L. BURNETT, Anesth. Analg. 68 328-332 (1989).
3. WEBER WV, JAWALEKAR KS and S.R. JAWALEKAR, Neurosci. Lett. 1115-120 (1975)
4. O.E. EL-KHATEEB, Status of ketamine in anesthesiology, E.F. Domino (Ed.) 414-417, EPP Books Ann Arbor, MI (1990)
5. SHULMAN SM, PENG ATC, BLANCATO LS, CUTRONE F and K. NYUNT, Status of ketamine in anesthesiology, E.F. Domino (Ed.), 395-402, EPP Books Ann Arbor, MI (1990).
6. B. BRUGUEROLLE and A.M. LOREC, Life. Sci. 54 PL315-319 (1994)
7. B. BRUGUEROLLE, L. ATTOLINI, A.M. LOREC and M. GANTENBEIN, Can. J Anaesth. 42 434-437 (1995).
8. M. GANTENBEIN, L. ATTOLINI and B. BRUGUEROLLE, J. Pharm. Pharmacol. 48 749-752 (1996).
9. B. BRUGUEROLLE and A.M. LOREC, Life. Sci. 52 PL165-167 (1993)
10. K. LESZCZYNSKA and S.T. KAU, J. Pharmacol. Meth. 27 85-93 (1992).
11. M. GANTENBEIN, L. ATTOLINI and B. BRUGUEROLLE, Can. J. Anaesth. 43 871-876 (1996)
12. B. BRUGUEROLLE and M. PRAT, J. Pharm. Pharmacol. 39 148-149 (1987).
13. M. BJORK, K.J. PETTRESON and G. OSTERLOF, J. Chromatogr. 533 229-234 (1990).
14. A.M. LOREC, B. BRUGUEROLLE, L. ATTOLINI and X. ROUCOULES, Ther. Drug. Monit. 16 592-595 (1994).
15. D.R. LU and F. MAO, J. Pharm. Sci. 82 537-542 (1993).
16. J.M. LOCH, J. POTTER and K.A. BACHMANN, Pharmacology 50 146-153 (1995).
17. L. ATTOLINI, M. GANTENBEIN and B. BRUGUEROLLE, Life Sci., 60 725-734 (1997).
18. M. TVERSKOY , M. OREN, M. VASKOVICH, I. DASHKOVSKY and I. KISSIN. Neurosci. Lett. 215 5-8 (1996).
19. O. PUCILOWSKI, Psychopharmacology 109 12-29 (1992).